Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer

Third and fourth line chemotherapy agents are not helpful in the setting of extensive stage small cell lung cancer (SCLC). We describe the case of a 43-year-old Korean patient with T4N3M1b extensive stage SCLC who responded remarkably well to treatment and experienced a prolonged progression-free su...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Sang Ok, Kim, Sun Young, Kim, Ju-Ock, Jung, Sung Soo, Park, Hee Sun, Moon, Jae Young, Kim, Sung Min, Lee, Jeong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567014/
https://www.ncbi.nlm.nih.gov/pubmed/26445616
http://dx.doi.org/10.1111/1759-7714.12198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567014/
https://www.ncbi.nlm.nih.gov/pubmed/26445616
http://dx.doi.org/10.1111/1759-7714.12198

Ejemplares similares